arrow
Back
M

Mark Lebwohl

icahn school of medicine at mount sinai

120H-index
1.4KPaper Count
5.5WCitation Count
Published Papers 502
Publication Date
Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review
err2026-08-11
err0
errOAAI
errApril W. Armstrong; Bruce E. Strober; Clive M. Liu; Jennifer C. Cather; Joseph F. Merola; Mark G. Lebwohl
errShare
errSave
Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials
err2026-08-07
err0
errOAAI
errApril W. Armstrong; Mark Lebwohl; Richard B. Warren; Akimichi Morita; Carle Paul; Diamant Thaçi; Matthias Augustin; Lluís Puig; Carolin Daamen; Janice Li; Alessandra Alió; Angela Aggrey-Amable; Julie Scotto; Zoran Popmihajlov; John Vaile; Bruce Strober
errShare
errSave
Treatment Patterns, Drug Survival, and Effectiveness of Tildrakizumab Among Patients with Prior Interleukin-17 Experience in the PPD CorEvitas Psoriasis Registry
err2026-07-30
err0
errOAAI
errMark G. Lebwohl; Ranga Gogineni; Asif Shaikh; Taylor Blachley; Thomas Eckmann; Alicia Beeghly; Jerry Bagel
errShare
errSave
Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease
err2026-06-01
err0
errOAAI
errLuis Puig; Tsen-Fang Tsai; Enrique R. Soriano; Tina Bhutani; Megan Miller; Alexa P. Kollmeier; Shu Li; Hewei Li; Sarah Ofori; Jeffrey Pawlikowski; Elizabeth Adamson; Melinda Gooderham; Angela Londoño Garcia; Mark Lebwohl; Peter Nash
errShare
errSave
The Misdiagnosis of Pemphigus Foliaceus as Psoriasis
err2026-05-07
err0
PREAI
errKateryna Karpoff; Omar Alani; Mark Lebwohl
errShare
errSave
Real-World Evidence of Dupilumab's Efficacy in Reducing Autoantibodies to Bullous Pemphigoid Antigens
err2026-05-02
err0
PREAI
errKateryna Karpoff; Anya Patel; Georgina Erfe; Emma Guttman-Yassky; Mark Lebwohl
errShare
errSave
Use of Oral JAK Inhibitors and a TYK2 Inhibitor in the Treatment of Psoriasis–Eczema Overlap (PsEma): A Retrospective Study
err2026-04-10
err0
PREAI
errMarley Cutrona; Sophie Guénin; Mindy Kresch-Vatch; Rabail Aslam; Emma Guttman-Yassky; Mark Lebwohl; Alexandra K. Golant
errShare
errSave
Systemic Corticosteroid Exposure in Patients with Atopic Dermatitis: A US Population-Based Study
err2026-02-22
err0
errOAAI
errChristopher G. Bunick; Ruth Ann Vleugels; Mark Lebwohl; April W. Armstrong; Ayman Grada; Emma Xiaomeng Yue; Madhi Saranadasa; Lani Wegrzyn; Elvira D’Andrea
errShare
errSave
Laboratory monitoring in patients with moderate to severe plaque psoriasis
err2025-12-31
err0
PREAI
errFenkel, Jonathan M.; Osborne, John A.; Armstrong, April W.; Strober, Bruce; Gold, Linda Stein; Cameron, Michael; Lebwohl, Mark
errShare
errSave
Real-World Treatment Patterns of Patients with Basal Cell Carcinoma Using Sonidegib and Vismodegib: Discontinuation Rates and Clinical Conditions During Treatment
err2025-12-20
err0
errOAAI
errMark G. Lebwohl; Darrell S. Rigel; Zeynep Eroglu; Victoria E. Barghout; Deepshekhar Gupta; Enrico Zanardo; Lynn Huynh; Mihran A. Yenikomshian; Nicholas Squittieri; Thomas J. Ferro; Kunal Patel
errShare
errSave
Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 Year
err2025-12-12
err0
errOAAI
errDiamant Thaçi; Akihiko Asahina; Wolf-Henning Boehncke; Alice B. Gottlieb; Mark Lebwohl; Richard B. Warren; Heather Edens; Barbara Ink; Rajan Bajracharya; Jason Coarse; Joseph F. Merola
errShare
errSave
Joint Position Statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on Routine Testing for Latent Tuberculosis Infection Prior To and During Treatment of Psoriasis Patients with IL-17 or IL-23 Inhibitors
err2025-11-17
err0
errOAAI
errAndrew Blauvelt; Bruce E. Strober; Guy S. Eakin; Leah McCormick Howard; Christy Langan; Peter C.M. van de Kerkhof; Lluís Puig; Mark G. Lebwohl; Ricardo Romiti; April W. Armstrong; Siew Eng Choon; Ravi Ramessur; Joel M. Gelfand; Joseph F. Merola; Kevin L. Winthrop; Tiago Torres
errShare
errSave
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication
err2025-11-06
err0
errOAAI
errDavid Rosmarin; Thierry Passeron; Amit G. Pandya; Pearl Grimes; John E. Harris; Seemal R. Desai; Mark Lebwohl; Mireille Ruer‑Mulard; Julien Seneschal; Albert Wolkerstorfer; Deanna Kornacki; Kang Sun; Kathleen Butler; Khaled Ezzedine
errShare
errSave
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents
err2025-11-06
err3
PREAI
errBissonnette, Robert; Soung, Jennifer; Hebert, Adelaide A.; Pink, Andrew E.; Pinter, Andreas; Moore, Angela Y.; Shi, Yuling; Wang, Wen-hui; Toth, Darryl P.; Miller-Kassamali, Megan; Cafone, Joseph; Jiang, Jingzhi; Li, Shu; DeKlotz, Cynthia M. C.; Nunes, Fabio; Lebwohl, Mark G.
errShare
errSave
Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials
err2025-10-24
err0
errOAAI
errKim A. Papp; James Q. Del Rosso; Mark G. Lebwohl; Melinda J. Gooderham; Adelaide A. Hebert; H. Chih-ho Hong; Leon H. Kircik; David M. Pariser; Linda Stein Gold; Bruce Strober; Melissa S. Seal; David Krupa; David H. Chu; Patrick Burnett; David R. Berk; Robert C. Higham
errShare
errSave
Remibrutinib in chronic spontaneous urticaria: 52-Week results from two phase 3 studies
err2025-10-18
err0
PREAI
errAna Maria Giménez-Arnau; Robert Szalewski; Michihiro Hide; Vipul Jain; Abdallah Khemis; Mark Lebwohl; Martin Metz; Giselle Mosnaim; Michael Palumbo; Ekin Şavk; Gordon Sussman; Irena Walecka-Herniczek; Bin Yang; Claire Field; Sibylle Haemmerle; Karine Lheritier; Paula G.P. Machado; El-Djouher Martzloff; Noriko Seko; Pengpeng Wang; Artem Zharkov; Sarbjit Saini
errShare
errSave
Risk of Nonmelanoma Skin Cancer in Patients with Moderate-to-Severe Atopic Dermatitis: A United States Population-Based Study
err2025-10-13
err0
errOAAI
errMark Lebwohl; Emma Yue; Whitney S. Krueger; Brian Berman; Christopher G. Bunick; Todd Schlesinger; Ayman Grada
errShare
errSave